Literature DB >> 29285169

miR-30b regulates chondrogenic differentiation of mouse embryo-derived stem cells by targeting SOX9.

Qingde Wa1, Peiheng He2, Shuai Huang2, Jianwei Zuo3, Xing Li2, Jinsong Zhu1, Song Hong1, Guoqing Lv1, Dongfeng Cai1, Dongliang Xu2, Xuenong Zou2, Yi Liu1.   

Abstract

The present study aimed to investigate the mechanisms underlying microRNA (miRNA)-mediated regulation of chondrogenic differentiation. Mouse embryo-derived stem cells C3H10T1/2 were cultured and chondrogenic differentiation was induced using transforming growth factor-β3 (TGF-β3). In addition, miRNA expression profiles were detected via miRNA array analysis, and quantitative polymerase chain reaction was performed to verify the differentially expressed miRNAs. Furthermore, bioinformatics software was used to predict the putative targets and the prediction was validated by dual-luciferase reporter assays and western blot analysis. In addition, cell proliferation and glycosaminoglycans were measured by a direct cell count method and alcian blue staining, respectively. Compared with the control group, 86 miRNAs were identified as differentially expressed in TGF-β3-induced cells and the expression levels of 28 miRNAs were increased while the remaining 58 miRNAs exhibited a decline in expression. Amongst the differentially expressed miRNAs, miR-30b expression was observed to have significantly decreased during chondrogenic differentiation. SOX9 is a target gene of miR-30b, and miR-30b inhibits SOX9 expression during chondrogenic differentiation. Furthermore, the alcian blue staining results demonstrated that miR-30b inhibited early chondrogenic differentiation. However, the data of the present study indicated that miR-30b had no influence on C3H10T1/2 cell line proliferation. In conclusion, miR-30b is a key negative regulator of TGF-β3-induced C3H10T1/2 cell chondrogenic differentiation, which functions by directly targeting SOX9.

Entities:  

Keywords:  SOX9; chondrogenic differentiation; miR-30b; mouse embryo-derived stem cells; target

Year:  2017        PMID: 29285169      PMCID: PMC5740517          DOI: 10.3892/etm.2017.5344

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination.

Authors:  Shu-Huei Hsiao; Kuan-Der Lee; Chia-Chen Hsu; Min-Jen Tseng; Victor X Jin; Wei-Sheng Sun; Yi-Chen Hung; Kun-Tu Yeh; Pearlly S Yan; Yen-Yu Lai; H Sunny Sun; Yen-Jung Lu; Yu-Sun Chang; Shaw-Jenq Tsai; Tim H-M Huang; Yu-Wei Leu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-19       Impact factor: 3.575

Review 4.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

5.  Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1/2 cells.

Authors:  Yoko Hashimoto; Mari Kobayashi; Etsuko Matsuzaki; Katsumasa Higashi; Fumi Takahashi-Yanaga; Aiko Takano; Masato Hirata; Fusanori Nishimura
Journal:  Cell Biol Int       Date:  2016-08-14       Impact factor: 3.612

Review 6.  Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells.

Authors:  Deborah Studer; Christopher Millan; Ece Öztürk; Katharina Maniura-Weber; Marcy Zenobi-Wong
Journal:  Eur Cell Mater       Date:  2012-07-24       Impact factor: 3.942

7.  Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.

Authors:  W F Xie; X Zhang; S Sakano; V Lefebvre; L J Sandell
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

8.  The miRNA pathway intrinsically controls self-renewal of Drosophila germline stem cells.

Authors:  Joseph K Park; Xiang Liu; Tamara J Strauss; Dennis M McKearin; Qinghua Liu
Journal:  Curr Biol       Date:  2007-02-22       Impact factor: 10.834

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

Review 10.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

View more
  4 in total

Review 1.  The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.

Authors:  Maria Rosa Iaquinta; Carmen Lanzillotti; Chiara Mazziotta; Ilaria Bononi; Francesca Frontini; Elisa Mazzoni; Lucia Oton-Gonzalez; John Charles Rotondo; Elena Torreggiani; Mauro Tognon; Fernanda Martini
Journal:  Theranostics       Date:  2021-04-30       Impact factor: 11.556

2.  MicroRNA-30a regulates chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells through targeting Sox9.

Authors:  Hongqi Zhang; Yunjia Wang; Guanteng Yang; Honggui Yu; Zhenhai Zhou; Mingxing Tang
Journal:  Exp Ther Med       Date:  2019-10-30       Impact factor: 2.447

Review 3.  Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review).

Authors:  Qing Zhang; Shousheng Liu; Jie Zhang; Xuefeng Ma; Mengzhen Dong; Baokai Sun; Yongning Xin
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

4.  MiR-539-3p inhibited chondrogenic differentiation in human adipose stem cells by targeting Sox9.

Authors:  Feng Qin; Fang Wang; Xiao-Ping Wang; Jie Chen; Feng-Hua Zeng; Cui-Lan Sun; Jia-Cuo Peng Mao; Chun-Liang Li
Journal:  J Orthop Surg Res       Date:  2022-03-18       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.